The Lancet, Volume 358, Issue 9287, Pages 1051 - 1056, 29 September 2001
Copyright © 2001 Elsevier Ltd All rights reserved.
Do better family planning services reduce abortion in Bangladesh?
Summary
Background
Fertility decline is often associated with an increase in contraception and abortion, but the causal relations are difficult to examine with non-experimental data. We aimed to assess the effects of family planning services on abortion rates in two similar areas.
Methods
We examined trends in overall abortion rates and rates for intended and unintended pregnancies in two similar areas typical of rural Bangladesh. We analysed Matlab Demographic Surveillance System (DSS) data on pregnancy outcomes between 1979 and 1998 in these areas, matching them to survey data on fertility preferences, which enabled us to identify pregnancies as intended or unintended.
Findings
Abortion rates were significantly lower in the area with better family planning services compared with the comparison area (1984—86, 2·2 vs 5·2; 1996—98, 2·3 vs 6·8). Abortion of unintended pregnancies is similar in both areas, but the higher levels of contraceptive use in the treatment area have led to lower levels of unintended pregnancy and abortion. The likelihood that an unintended pregnancy will be aborted has increased in both areas but the decrease in unintended pregnancies was sufficiently large in the treatment area to offset this increase.
Interpretations
Abortion may increase during the fertility transition in less-developed countries as the desire to limit family size increases unless there is widespread availability of quality family planning services.
This article is made available free of charge, as a service to our users.
Please login to access the full article, or register if you do not yet have a username and password.
Please login to access the full article, or register if you do not yet have a username and password.
Already Registered? Please Login
New to TheLancet.com?
TheLancet.com is the online home of:- The Lancet
- The Lancet Diabetes & Endocrinology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The Lancet Respiratory Medicine
No comments:
Post a Comment